Despite the high level of all the projects, the jury awarded first prize to PriorityCare, a project developed by a multidisciplinary team from the Madrid Hospital Foundation that proposes transform th...
Read moreThe AI revolution in Pharmaceutical R&D is transitioning from experimental curiosity to operational necessity. This transformation is supported by quantifiable operational improvements: AI-enabled dis...
Read moreBiorce has closed a $52.5 million investment round (approximately €44.3 million) with the aim of accelerating the development of its artificial intelligence software for clinical trials and strength...
Read moreContextflow SEARCH Lung CT continues to prove useful in differentiating lung diseases.
Read moreWhen we talk about the applications of artificial intelligence in medicine, we have to mention the different specialties that can benefit from its tools. We have already mentioned the case of AI an...
Read moreThe event gathered more than 140 speakers and 70 presentations over two days. Two sessions debated the impact of new technologies and digital disruption in healthcare, led by Biocat and EATRIS.
Read moreAlthough artificial intelligence (A.I.) has experienced rapid growth over the past few years, the term A.I. was first coined by John McCarthy (1) in 1955. A.I. is defined as the ability of machines...
Read moreEuropean Biotechnology Life Science and Industry Magazine published the article “A pioneering real AI drug discovery technology” describing the approach of SOM Biotech.
Read more